Lun-Hsiang Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lun-Hsiang Yuan has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Shi-Wei Huang
Department of Urology, National Taiwan University Hospital, Yunlin Branch, Yunlin, Taiwan
4 shared publications Yu-Wen Huang
Department of Urology, National Taiwan University Hospital, Yunlin Branch, Yunlin, Taiwan (R.O.C.)
2 shared publicationsC. -C. Wu
Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan
1 shared publicationC. -H. Liao
Cardinal Tien Hospital, New Taipei City, Taiwan
1 shared publicationC. -H. Tsai
Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan
1 shared publicationC. -M. Pen
Chung Shan Medical University Hospital, Taichung, Taiwan
1 shared publication
Latest Publications
- 24 June 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-10
Introducing Senhance robotic totally extraperitoneal (TEP) hernioplasty: initial experiences, learning curve, and mid-term outcomes from a single center
Laparoscopic totally extraperitoneal (TEP) inguinal hernioplasty offers less pain and faster recovery than open repair, but it is technically demanding. The Senhance surgical system integrates eye-tracking, haptic feedback, and reusable instruments; however, robust clinical data in TEP remain limited. Between January 2019 and July 2023, we prospectively enrolled 109 adults who underwent Senhance-assisted TEP (S-TEP) at a single center; 57 retrospective laparoscopic TEP (L-TEP) served as an operative-time benchmark. Patients with prior pelvic-malignancy surgery, ascites, peritoneal dialysis, emergency surgeries, or general anesthesia intolerance were excluded. Patient demographics, hernia type, operative time, 30-day complications, pain scores, length of stay, recurrence, and chronic pain were recorded systematically. We used cumulative-sum (CUSUM) analysis to assess the learning curve, and compare the operative-time with L-TEP after overlap weighing balance. All S-TEP procedures were completed robotically without conversions or intra-operative complications. CUSUM revealed a three-phase learning curve, reaching proficiency after ≈50 cases as mean operative time fell from 145 ± 32 min to 93 ± 18 min (p < 0.001). Thirty-day morbidity was 6.4%, mainly early seroma or hematoma. At a median 50-month follow-up, recurrence and chronic pain rates were 0.9 and 1.8%, respectively. Weighted analysis showed that operative time in the mature S-TEP phase matched L-TEP. S-TEP is feasible and safe for inguinal hernioplasty, achieving favorable mid-term outcomes comparable to laparoscopic standards after a learning curve of roughly 50 cases. Further validation through larger, multicenter studies are warranted.
- 24 June 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-10
Introducing Senhance robotic totally extraperitoneal (TEP) hernioplasty: initial experiences, learning curve, and mid-term outcomes from a single center
Laparoscopic totally extraperitoneal (TEP) inguinal hernioplasty offers less pain and faster recovery than open repair, but it is technically demanding. The Senhance surgical system integrates eye-tracking, haptic feedback, and reusable instruments; however, robust clinical data in TEP remain limited. Between January 2019 and July 2023, we prospectively enrolled 109 adults who underwent Senhance-assisted TEP (S-TEP) at a single center; 57 retrospective laparoscopic TEP (L-TEP) served as an operative-time benchmark. Patients with prior pelvic-malignancy surgery, ascites, peritoneal dialysis, emergency surgeries, or general anesthesia intolerance were excluded. Patient demographics, hernia type, operative time, 30-day complications, pain scores, length of stay, recurrence, and chronic pain were recorded systematically. We used cumulative-sum (CUSUM) analysis to assess the learning curve, and compare the operative-time with L-TEP after overlap weighing balance. All S-TEP procedures were completed robotically without conversions or intra-operative complications. CUSUM revealed a three-phase learning curve, reaching proficiency after ≈50 cases as mean operative time fell from 145 ± 32 min to 93 ± 18 min (p < 0.001). Thirty-day morbidity was 6.4%, mainly early seroma or hematoma. At a median 50-month follow-up, recurrence and chronic pain rates were 0.9 and 1.8%, respectively. Weighted analysis showed that operative time in the mature S-TEP phase matched L-TEP. S-TEP is feasible and safe for inguinal hernioplasty, achieving favorable mid-term outcomes comparable to laparoscopic standards after a learning curve of roughly 50 cases. Further validation through larger, multicenter studies are warranted.
- 23 May 2025
- Published by Springer Nature in Hernia
- Vol. 29 (1) , 1-11
Senhance versus da Vinci robotic inguinal hernia repair: a multi-center propensity-weighted study
Purpose Inguinal hernia repair is a common surgical procedure, with robotic-assisted surgery increasingly adopted as a minimally invasive approach. While the da Vinci Surgical System offers advantages, its high cost motivates the search for more economical alternatives. The Senhance surgical system, a laparoscopy-based platform with reusable instruments, presents a potential cost-effective option. This study aims to compare the clinical outcomes and preliminary costs of Senhance and da Vinci robotic platforms in inguinal hernia repair. Methods This retrospective, observational study analyzed data from eight teaching hospitals using either the Senhance (n = 167) or da Vinci (n = 278) system for robotic inguinal hernioplasty (January 2019–January 2024). Propensity score overlap weighting was used to balance baseline characteristics between groups. Primary outcomes were operative time (ORTIME), console time (CONTIME), and total length of hospital stay (LOS). Secondary outcomes included postoperative length of stay (Post LOS), intraoperative and postoperative complications, and recurrence rate. Results After overlap weighting, the Senhance group demonstrated significantly shorter operative time (108.42 ± 41.32 vs. 150.50 ± 61.51 min, p < 0.001) and console time (40.95 ± 44.6 vs. 65.56 ± 63.36 min, p = 0.005) compared to the da Vinci group. There were no significant differences in intraoperative or postoperative complications, or recurrence rates between the two groups. Postoperative length of stay was also significantly shorter in the Senhance group (2.24 ± 0.69 vs. 2.63 ± 1.09 days, p = 0.007). Preliminary cost analysis showed lower out-of-pocket expenses for patients undergoing Senhance robotic hernioplasty. Conclusions The Senhance robotic system was associated with reduced operative duration and postoperative hospital stay compared to the da Vinci system in inguinal hernia repair, without increasing complications or recurrence. These findings suggested that the Senhance system may be a cost-effective alternative to the da Vinci platform for robotic inguinal hernia repair. Further studies are warranted to investigate long-term outcomes and comprehensive cost-effectiveness.
- 23 May 2025
- Published by Springer Nature in Hernia
- Vol. 29 (1) , 1-11
Senhance versus da Vinci robotic inguinal hernia repair: a multi-center propensity-weighted study
Purpose Inguinal hernia repair is a common surgical procedure, with robotic-assisted surgery increasingly adopted as a minimally invasive approach. While the da Vinci Surgical System offers advantages, its high cost motivates the search for more economical alternatives. The Senhance surgical system, a laparoscopy-based platform with reusable instruments, presents a potential cost-effective option. This study aims to compare the clinical outcomes and preliminary costs of Senhance and da Vinci robotic platforms in inguinal hernia repair. Methods This retrospective, observational study analyzed data from eight teaching hospitals using either the Senhance (n = 167) or da Vinci (n = 278) system for robotic inguinal hernioplasty (January 2019–January 2024). Propensity score overlap weighting was used to balance baseline characteristics between groups. Primary outcomes were operative time (ORTIME), console time (CONTIME), and total length of hospital stay (LOS). Secondary outcomes included postoperative length of stay (Post LOS), intraoperative and postoperative complications, and recurrence rate. Results After overlap weighting, the Senhance group demonstrated significantly shorter operative time (108.42 ± 41.32 vs. 150.50 ± 61.51 min, p < 0.001) and console time (40.95 ± 44.6 vs. 65.56 ± 63.36 min, p = 0.005) compared to the da Vinci group. There were no significant differences in intraoperative or postoperative complications, or recurrence rates between the two groups. Postoperative length of stay was also significantly shorter in the Senhance group (2.24 ± 0.69 vs. 2.63 ± 1.09 days, p = 0.007). Preliminary cost analysis showed lower out-of-pocket expenses for patients undergoing Senhance robotic hernioplasty. Conclusions The Senhance robotic system was associated with reduced operative duration and postoperative hospital stay compared to the da Vinci system in inguinal hernia repair, without increasing complications or recurrence. These findings suggested that the Senhance system may be a cost-effective alternative to the da Vinci platform for robotic inguinal hernia repair. Further studies are warranted to investigate long-term outcomes and comprehensive cost-effectiveness.
- Open Access
- 1 January 2025
- Published by XMLink in The World Journal of Men's Health
- Vol. 43 (4) , 918-933
The In-depth Comparative Analysis of Four Large Language AI Models for Risk Assessment and Information Retrieval from Multi-Modality Prostate Cancer Work-up Reports
Yuan LH, et al. World J Mens Health. 2024 Dec;42:e104. https://doi.org/10.5534/wjmh.240173
- 1 January 2025
- Published by XMLink in The World Journal of Men's Health
- Vol. 43 (4) , 918-933
Open AccessThe In-depth Comparative Analysis of Four Large Language AI Models for Risk Assessment and Information Retrieval from Multi-Modality Prostate Cancer Work-up Reports
Yuan LH, et al. World J Mens Health. 2024 Dec;42:e104. https://doi.org/10.5534/wjmh.240173
- Open Access
- 6 August 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (8) , e9117
Robotic‐assisted laparoscopic radical nephrectomy and lymph nodes dissection using Senhance robotic system and Senhance ultrasonic energy device: A case report
Key Clinical Message: Using the Senhance robotic system and Senhance ultrasonic energy device for robotic‐assisted radical nephrectomy with hilum lymph node dissection demonstrated safety and feasibility in managing a large renal tumor without the need for open conversion or transfusion, offering a cost‐effective solution.
- 6 August 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (8) , e9117
Open AccessRobotic‐assisted laparoscopic radical nephrectomy and lymph nodes dissection using Senhance robotic system and Senhance ultrasonic energy device: A case report
Key Clinical Message: Using the Senhance robotic system and Senhance ultrasonic energy device for robotic‐assisted radical nephrectomy with hilum lymph node dissection demonstrated safety and feasibility in managing a large renal tumor without the need for open conversion or transfusion, offering a cost‐effective solution.
- 19 July 2024
- Published by Wiley in BJU International
- Vol. 134 (5) , 818-825
Prospective study of urinary incontinence recovery following endoscopic enucleation of the prostate
Objective: To investigate the clinical trajectories and identify risk factors linked to post‐enucleation urinary incontinence (UI). Patients and Methods: In this prospective study (April 2020 to March 2022) at a single institution, 316 consecutive patients receiving endoscopic enucleation due to benign prostatic enlargement were included. Patient information and perioperative details were collected. Follow‐ups, from 1 to 6 months, assessed postoperative UI using International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form and a four‐item pad questionnaire, classified per International Continence Society definitions. Logistic regression analysed predictors at 1 week, while generalised estimating equation assessed risk factors from 1 to 3 months postoperatively. Results: Patients with a median prostate volume of 57 mL underwent enucleation, with 22.5% experiencing postoperative UI at 1 week, 5.6% at 3 months, decreasing to 1.9% at 6 months. Multivariable analysis identified age (>80 years), specimen weight (>70 g), en bloc with anteroposterior dissection, and anal tone (Digital Rectal Examination Scoring System score <3) as potential factors influencing UI. Subgroup analysis revealed that specimen weight was associated with both continuous and stress UI. Anal tone was related to both other types and stress UI, while overactive bladder symptoms were associated with urge UI. Conclusion: In summary, our study elucidates transient risk factors contributing to temporary post‐enucleation UI after prostatectomy. Informed decisions and personalised interventions can effectively alleviate concerns regarding postoperative UI.
- 19 July 2024
- Published by Wiley in BJU International
- Vol. 134 (5) , 818-825
Prospective study of urinary incontinence recovery following endoscopic enucleation of the prostate
Objective: To investigate the clinical trajectories and identify risk factors linked to post‐enucleation urinary incontinence (UI). Patients and Methods: In this prospective study (April 2020 to March 2022) at a single institution, 316 consecutive patients receiving endoscopic enucleation due to benign prostatic enlargement were included. Patient information and perioperative details were collected. Follow‐ups, from 1 to 6 months, assessed postoperative UI using International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form and a four‐item pad questionnaire, classified per International Continence Society definitions. Logistic regression analysed predictors at 1 week, while generalised estimating equation assessed risk factors from 1 to 3 months postoperatively. Results: Patients with a median prostate volume of 57 mL underwent enucleation, with 22.5% experiencing postoperative UI at 1 week, 5.6% at 3 months, decreasing to 1.9% at 6 months. Multivariable analysis identified age (>80 years), specimen weight (>70 g), en bloc with anteroposterior dissection, and anal tone (Digital Rectal Examination Scoring System score <3) as potential factors influencing UI. Subgroup analysis revealed that specimen weight was associated with both continuous and stress UI. Anal tone was related to both other types and stress UI, while overactive bladder symptoms were associated with urge UI. Conclusion: In summary, our study elucidates transient risk factors contributing to temporary post‐enucleation UI after prostatectomy. Informed decisions and personalised interventions can effectively alleviate concerns regarding postoperative UI.
- Open Access
- 29 March 2024
- Published by Wolters Kluwer Health in Urological Science
- Vol. 35 (1) , 24-30
Initial experiences and troubleshooting of Senhance robotic system: A community hospital perspective
Purpose: The purpose of this study is to demonstrate the feasibility and safety of the Senhance robotic system in urologic surgeries. Materials and methods: Patients were included prospectively from July 2018 to December 2020. The exclusion criteria included severe cardiopulmonary diseases and previous extensive abdominal surgeries. Institutional approval and informed consent were obtained. We used the Clavien-Dindo classification system to evaluate the complications that occurred within 30 days after surgery. Common technical and mechanical events encountered were also recorded. Results: A total of 173 patients were recruited. The median age was 65 (58–74) years, and the median body mass index was 24.7 (16.5–35.6) kg/m2. Seventeen (9.8%) patients had previously undergone abdominal surgeries. Eighty-three (48%) cases had total extraperitoneal hernioplasty and 32 (18.5%) cases radical prostatectomy, which were the largest 2 surgeries in our study. Sixty-one (35.3%) patients received surgeries due to malignancy. The median docking time was 5 (1–35) minutes. There were 28 (16.2%) cases with grade I complications and 9 (5.2%) cases with grade II complications. Only one case of a grade IIIb complication occurred during radical prostatectomy. No grade IV complications or mortalities were noted. Robotic arm collisions and forces exceeding the limit were the most commonly encountered problems intraoperatively. Conclusion: In our initial experiences, the Senhance robotic system was feasible in oncologic and nononcologic urologic surgeries and had acceptable outcomes. The haptic feedback system is unique and requires a learning period. This system may serve as an alternative tool for robotic urologic surgeries.
- 29 March 2024
- Published by Wolters Kluwer Health in Urological Science
- Vol. 35 (1) , 24-30
Open AccessInitial experiences and troubleshooting of Senhance robotic system: A community hospital perspective
Purpose: The purpose of this study is to demonstrate the feasibility and safety of the Senhance robotic system in urologic surgeries. Materials and methods: Patients were included prospectively from July 2018 to December 2020. The exclusion criteria included severe cardiopulmonary diseases and previous extensive abdominal surgeries. Institutional approval and informed consent were obtained. We used the Clavien-Dindo classification system to evaluate the complications that occurred within 30 days after surgery. Common technical and mechanical events encountered were also recorded. Results: A total of 173 patients were recruited. The median age was 65 (58–74) years, and the median body mass index was 24.7 (16.5–35.6) kg/m2. Seventeen (9.8%) patients had previously undergone abdominal surgeries. Eighty-three (48%) cases had total extraperitoneal hernioplasty and 32 (18.5%) cases radical prostatectomy, which were the largest 2 surgeries in our study. Sixty-one (35.3%) patients received surgeries due to malignancy. The median docking time was 5 (1–35) minutes. There were 28 (16.2%) cases with grade I complications and 9 (5.2%) cases with grade II complications. Only one case of a grade IIIb complication occurred during radical prostatectomy. No grade IV complications or mortalities were noted. Robotic arm collisions and forces exceeding the limit were the most commonly encountered problems intraoperatively. Conclusion: In our initial experiences, the Senhance robotic system was feasible in oncologic and nononcologic urologic surgeries and had acceptable outcomes. The haptic feedback system is unique and requires a learning period. This system may serve as an alternative tool for robotic urologic surgeries.